KDR Gene as a Predictive Biomarker of Response to Regorafenib in Patients With Metastatic Colorectal Cancer (mCRC)
Journal of Pharmacogenomics & Pharmacoproteomics
doi 10.4172/2153-0645.1000173
Full Text
Open PDFAbstract
Available in full text
Date
January 1, 2017
Authors
Publisher
OMICS Publishing Group